$4.78
0.030.63%
At close: Dec 15, 4:00 PM EST
$5.17
0.398.16%
After Hours: 7:57 PM EST
Comments
Loading...
Biodexa Pharmaceuticals (BDRX) Stock Price, Quote, News & History
BDRXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biodexa Pharmaceuticals (BDRX) stock?
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Who are Biodexa Pharmaceuticals (BDRX) competitors?
Other companies in Biodexa Pharmaceuticals’s space includes: Dermata Therapeutics Inc (NASDAQ:DRMA), Bio Green Med Solution Inc (NASDAQ:BGMSP), Can Fite Biofarma Ltd (AMEX:CANF), AquaBounty Technologies Inc (NASDAQ:AQB) and Indaptus Therapeutics Inc (NASDAQ:INDP).
What is the forecast, or price target, for Biodexa Pharmaceuticals (BDRX) stock?
Biodexa Pharmaceuticals has a consensus price target of $8.00.
What is the current price for Biodexa Pharmaceuticals (BDRX)?
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $5.17 last updated December 15, 2025 at 7:57 PM EST.
Does Biodexa Pharmaceuticals (BDRX) pay a dividend?
There are no upcoming dividends for Biodexa Pharmaceuticals.
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals does not have any upcoming earnings scheduled.
Is Biodexa Pharmaceuticals (BDRX) going to split?
There is no upcoming split for Biodexa Pharmaceuticals.
What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
